Patents by Inventor Shai Yehoshua Schubert

Shai Yehoshua Schubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210022952
    Abstract: Apparatus and devices for intermittently and sequentially compressing a body site include a first segment cooperative with a fluid chamber, the fluid chamber adapted for inflation by fluid; and a second segment cooperative with the first segment, the second segment housing a temperature sensitive material, wherein the temperature sensitive material is uniquely compartmentalized in the second segment. Methods for using said apparatus and devices include site specific treatment to achieve a desired temperature of the underlying tissue.
    Type: Application
    Filed: October 15, 2020
    Publication date: January 28, 2021
    Applicant: Portable Therapeutix, LLC
    Inventor: Shai Yehoshua Schubert
  • Patent number: 10813825
    Abstract: Apparatus and devices for intermittently and sequentially compressing a body site include a first segment cooperative with a fluid chamber, the fluid chamber adapted for inflation by fluid; and a second segment cooperative with the first segment, the second segment housing a temperature sensitive material, wherein the temperature sensitive material is uniquely compartmentalized in the second segment. Methods for using said apparatus and devices include site specific treatment to achieve a desired temperature of the underlying tissue.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: October 27, 2020
    Assignee: Portable Therapeutix, LLC
    Inventor: Shai Yehoshua Schubert
  • Patent number: 9889232
    Abstract: In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to replace lost cells or to restore function to tissue damaged due to disease, injury or genetic defect. In various embodiments, the treatment includes a semisolid hydrogel embedded with liposomes. The liposomes can contain an effector molecule or molecules. When phagocytic cells such as monocytes infiltrate the hydrogel, they encounter the liposomes and incorporate the liposomes carrying the effector molecules into the cells. In some embodiments, the effector molecules can induce angiogenesis. The matrix can contain other effector molecules designed to attract specific cells to the matrix. The cells can also remain in the matrix and secret molecules such as proteins and hormones that will diffuse through the matrix material to the surrounding tissue.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: February 13, 2018
    Assignee: BONUS CELLORA LTD.
    Inventor: Shai Yehoshua Schubert
  • Publication number: 20150050332
    Abstract: In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to replace lost cells or to restore function to tissue damaged due to disease, injury or genetic defect. In various embodiments, the treatment includes a semisolid hydrogel embedded with liposomes. The liposomes can contain an effector molecule or molecules. When phagocytic cells such as monocytes infiltrate the hydrogel, they encounter the liposomes and incorporate the liposomes carrying the effector molecules into the cells. In some embodiments, the effector molecules can be genetic material encoding the expression of specific proteins such as transcription factors, the expression of which can initiate the reprogramming of the cells. In other embodiments, the effector molecules can induce angiogenesis. In other embodiments, the effector molecules are tumor antigens.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 19, 2015
    Inventor: Shai Yehoshua Schubert
  • Publication number: 20140316314
    Abstract: Described are improved apparatus and devices for intermittently and sequentially compressing a body site and methods for using said apparatus and devices, especially for site specific treatment to achieve a desired temperature of the underlying tissue. The apparatus includes a first segment cooperative with a fluid chamber, the fluid chamber adapted for inflation by fluid; and a second segment cooperative with the first segment, the second segment housing a temperature sensitive material, wherein the temperature sensitive material is uniquely compartmentalized in the second segment.
    Type: Application
    Filed: July 1, 2014
    Publication date: October 23, 2014
    Inventor: Shai Yehoshua Schubert
  • Publication number: 20120323152
    Abstract: Described are improved apparatus and devices for intermittently and sequentially compressing a body site and methods for using said apparatus and devices, especially for site specific treatment to achieve a desired temperature of the underlying tissue. The apparatus includes a first segment cooperative with a fluid chamber, the fluid chamber adapted for inflation by fluid; and a second segment cooperative with the first segment, the second segment housing a temperature sensitive material, wherein the temperature sensitive material is uniquely compartmentalized in the second segment.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 20, 2012
    Inventor: Shai Yehoshua Schubert
  • Publication number: 20120093914
    Abstract: In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to replace lost cells or to restore function to tissue damaged due to disease, injury or genetic defect. In various embodiments, the treatment includes a semisolid hydrogel embedded with liposomes. The liposomes can contain an effector molecule or molecules. When phagocytic cells such as monocytes infiltrate the hydrogel, they encounter the liposomes and incorporate the liposomes carrying the effector molecules into the cells. In some embodiments, the effector molecules can be genetic material encoding the expression of specific proteins such as transcription factors, the expression of which can initiate the reprogramming of the cells. In other embodiments, the effector molecules can induce angiogenesis. In other embodiments, the effector molecules are tumor antigens.
    Type: Application
    Filed: November 24, 2009
    Publication date: April 19, 2012
    Applicant: MOMA THERAPEUTICS
    Inventor: Shai Yehoshua Schubert